Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Current Deferred Tax Assets: 2014-2015

Historic Current Deferred Tax Assets for Ani Pharmaceuticals (ANIP) over the last 1 years, with Sep 2015 value amounting to $8.3 million.

  • Ani Pharmaceuticals' Current Deferred Tax Assets was N/A to $8.3 million in Q3 2015 from the same period last year, while for Sep 2015 it was $8.3 million, marking a year-over-year change of. This contributed to the annual value of $7.6 million for FY2014, which is N/A change from last year.
  • As of Q3 2015, Ani Pharmaceuticals' Current Deferred Tax Assets stood at $8.3 million, which was up 3.34% from $8.0 million recorded in Q2 2015.
  • Ani Pharmaceuticals' 5-year Current Deferred Tax Assets high stood at $8.3 million for Q3 2015, and its period low was $7.6 million during Q4 2014.
  • For the 2-year period, Ani Pharmaceuticals' Current Deferred Tax Assets averaged around $7.9 million, with its median value being $7.9 million (2015).